MiMedx Group, Inc. announced a $25 million patent license agreement with a wound care competitor, resolving patent infringement claims. The licensee will pay $5 million annually over five years, with the first payment already received. This deal grants a non-exclusive license and highlights MiMedx's strong intellectual property portfolio in placental biologics. The agreement provides MiMedx with steady cash flow and supports ongoing innovation and patent protection efforts.
MiMedx's $25 million patent license agreement provides context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 02:12 WIB: out of 150 priced US health stocks, 87 rose and 62 fell. Notable movers include HIMS at USD 29.26 with a 4.80% increase and 88% buy order activity, GSK at USD 48.52 down 4.75% with 100% buy orders, and BSX at USD 43.05 down 4.46% with 86% sell orders and a typical hold time of 81 days.
SpaceX reported a strong Q3 with revenue up 161% year-over-year to $14.6 billion and a net profit of $4.4 billion, reversing last year's loss. Starlink, its satellite internet service, grew revenue by nearly 70% to $5.2 billion and added 1.6 million ...
SPIE, a leading European multi-technical services provider, has signed an agreement to acquire a 76% stake in SAR ANLAGENBAU GmbH, a major electrical engineering and automation firm based in Austria and Germany. This acquisition will enhance SPIE's p...
SPIE, a European leader in energy and communication services, has agreed to acquire a 76% stake in SAR ANLAGENBAU GmbH, a key electrical engineering and automation firm in Austria and Germany. This acquisition will broaden SPIE's service portfolio in...
The global dermatological therapeutics market is projected to grow from about $43 billion in 2025 to $97 billion by 2034, with a compound annual growth rate of around 10%. This growth is fueled by increasing cases of acne, psoriasis, and other chroni...
Blockchain.com has launched TRX options trading, providing easier access to TRON's native token through its platform. This move expands the TRON ecosystem's reach by simplifying options trading for retail and institutional users worldwide. TRON, know...
